Suchergebnisse - "LoRusso, Patricia M"

PubPharm (33)

1

Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors : a phase I study

enthalten in: Journal for immunotherapy of cancer | 2022

von Naing, A. | Powderly, J. | Nemunaitis, J. | +11

ErratumIn: J Immunother Cancer. 2022 Oct;10(10):. - PMID 36283739

2

Identifying treatment options for BRAFV600 wild-type metastatic melanoma : A SU2C/MRA genomics-enabled clinical trial

enthalten in: PloS one | 2021

von LoRusso, P. | Sekulic, A. | Sosman, J. | +44

3

A Phase I Study of DLYE5953A, an Anti-LY6E Antibody Covalently Linked to Monomethyl Auristatin E, in Patients with Refractory Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Tolaney, S. | Do, K. | Eder, J. | +16

4

An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer

enthalten in: Thyroid : official journal of the American Thyroid Association | 2020

von Bible, K. | Menefee, M. | Lin, C. | +24

5

Assessment of effects of repeated oral doses of fedratinib on inhibition of cytochrome P450 activities in patients with solid tumors using a cocktail approach

enthalten in: Cancer chemotherapy and pharmacology | 2020

von Ogasawara, K. | LoRusso, P. | Olszanski, A. | +5

6

Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer

enthalten in: Investigational new drugs | 2019

von Goff, L. | Azad, N. | Stein, S. | +10

ErratumIn: Invest New Drugs. 2018 Oct 18;:. - PMID 30334109

7

First-in-human study of the anti-HB-EGF antibody U3-1565 in subjects with advanced solid tumors

enthalten in: Investigational new drugs | 2019

von Moore, K. | Bendell, J. | LoRusso, P. | +5

8

Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2018

von Von Hoff, D. | Rasco, D. | Heath, E. | +16

9

A phase I dose-escalation study of the safety and pharmacokinetics of a tablet formulation of voxtalisib, a phosphoinositide 3-kinase inhibitor, in patients with solid tumors

enthalten in: Investigational new drugs | 2018

von Mehnert, J. | Edelman, G. | Stein, M. | +7

10

A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2017

von Infante, J. | Cohen, R. | Kim, K. | +6

ErratumIn: Invest New Drugs. 2017 Jul 5;:. - PMID 28676972